✦ LIBER ✦

Loss of Glycemic Control in Patients with Type 2 Diabetes Mellitus Who Were Receiving Initial Metformin, Sulfonylurea, or Thiazolidinedione Monotherapy

✍ Scribed by Dr. Aylin A. Riedel; Mr. Herbert Heien; Ms. Jenifer Wogen; Dr. Craig A. Plauschinat

Book ID: 115049576
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 84 KB
Volume: 27
Category: Article
ISSN: 0277-0008
DOI: 10.1592/phco.27.8.1102

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Colesevelam, Rosiglitazone, o

Effects of Colesevelam, Rosiglitazone, or Sitagliptin on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Metformin Monotherapy

✍ Rigby, Scott; Handelsman, Yehuda; Lai, Yu-Ling; Abby, Stacey; Tao, Ben; Jones, M 📂 Article 📅 2010 🏛 American Association of Clinical Endocrinologists 🌐 English ⚖ 308 KB

Comparative efficacy of exenatide versus

Comparative efficacy of exenatide versus insulin glargine on glycemic control in type 2 diabetes mellitus patients inadequately treated with metformin monotherapy

✍ Karagianni, P; Polyzos, SA; Kartali, N; Zografou, I; Sambanis, C 📂 Article 📅 2013 🏛 Versita 🌐 English ⚖ 283 KB

Effect on Glycemic Control of Exenatide

Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

✍ Fineman, Mark S. (author);Bicsak, Thomas A. (author);Shen, Larry Z. (author);Tay 📂 Article 📅 2003 🏛 American Diabetes Association 🌐 English ⚖ 156 KB

Effect on Glycemic Control of Exenatide

Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

✍ Fineman, Mark S. (author);Bicsak, Thomas A. (author);Shen, Larry Z. (author);Tay 📂 Article 📅 2003 🏛 American Diabetes Association 🌐 English ⚖ 156 KB

Initiation of insulin treatment with pre

Initiation of insulin treatment with pre-meal or post-meal Humalog® Mix25™ twice daily improves glycemic control in elderly patients with type 2 diabetes who are not well-controlled with sulfonylureas

✍ Matthias Herz; Zvonko Milicevic; Bin Sun 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

A comparison of twice-daily exenatide an

A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study

✍ M. A. Nauck; S. Duran; D. Kim; D. Johns; J. Northrup; A. Festa; R. Brodows; M. T 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 196 KB